Karuna Three-For-Three As Another KarXT Schizophrenia Trial Hits Primary Endpoint

 
• By Alaric DeArment
Karuna announced results of a third positive study of KarXT in schizophrenia • Source: Shutterstock

More from Clinical Trials

More from R&D